ARE THERE ANY PROGNOSTİC PARAMETERS IN PREGNANT WOMEN WITH COVID-19 : A CROSS-SECTİONAL RESEARCH

Aım: Mean platelet volume (MPV) is an important indicator of inflammatory and contagious diseases. The hypothesis of the current study was that COVID-19 might affect platelet volume indices since it causes inflammation as in other viral infections and changing MPV value by treatment in pregnant patients with-COVID-19. Second aim to investigate there are any prognostic marker for COVID-19 illness in pregnant patients. Material and method: We retrospectively evaluated 169 pregnant COVID-19 patients who were admitted to a tertiary care hospital between March 2020 and December 2020. Full blood counts and biochemistry parameters, including C-reactive protein, ferritin, d-dimer, and procalcitonin were collected on admission and discharge. In addition, we compared the radiological classification of pulmonary computed tomography scans with intensive care requirement and vital signs such as fever, oxygen saturation, and pulse rate. Results: The change in MPV decreased with increasing oxygen saturation level and increased with the prolonged length of hospital stay. Only lymphocyte count, which is a component of the hemogram panel and an important prognostic parameter in COVID-19 monitoring, positively correlated with C-reactive protein, ferritin, and procalcitonin, but not with D-dimer and MPV value. Conclusıon: Mean platelet volume is an important laboratory marker for both pregnant and non-pregnant COVID-19 patients. It is as valuable as lymphocytes owing to its low measurement cost and rapid study time. Our study is significant due to the relatively higher number of participants compared to other studies and its particular focus on pregnant patients.